Related Experiment Videos

[Surgical treatment of ischemic mitral regurgitation]

M Hachida1, M Endo, Y Bonkohara

  • 1Department of Cardiovascular Surgery, Tokyo Women's Medical College, Japan.

[Zasshi] [Journal]. Nihon Kyobu Geka Gakkai
|July 1, 1994
PubMed

Insights

Surgical treatment for ischemic mitral regurgitation, a condition with high mortality, yielded satisfactory results. Therapeutic strategies incorporating mitral plasty or valve replacement, often with coronary artery bypass grafting, improved outcomes in patients with heart disease.

Area of Science:

  • Cardiology
  • Cardiac Surgery
  • Heart Valve Disease

Context:

  • Ischemic heart disease frequently causes mitral regurgitation.
  • This condition is associated with significant mortality, even after open-heart surgery.
  • Understanding pathological subtypes is crucial for surgical planning.

Purpose:

  • To report outcomes of surgical interventions for mitral regurgitation secondary to ischemic heart disease.
  • To analyze differences in presentation and outcomes between mitral regurgitation subtypes: papillary muscle dysfunction (PMD) and papillary muscle rupture (PR).

Summary:

  • This study reviewed 16 patients with ischemic mitral regurgitation, categorized into PMD (n=12) and PR (n=4) groups.
  • PMD patients often had left ventricular failure; PR patients were older with renal failure.
  • Surgical approaches included mitral plasty (PMD) and valve replacement (PR), frequently combined with coronary artery bypass grafting.
  • No operative deaths occurred; one hospital death (PR group) and three late deaths (PMD group) were recorded.

Impact:

  • Surgical management of ischemic mitral regurgitation, tailored to pathological findings, can achieve satisfactory results.
  • Early identification and appropriate surgical intervention are key to improving survival rates.
  • Further research into optimizing therapeutic strategies for these complex cases is warranted.

Related Concept Videos